Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan D Voss

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
JCO Precision Oncology|June 22, 2022
Gamma Secretase Inhibition for a Child With Metastatic Glomus Tumor and Activated NOTCH1Ellen Zhang, Amber Miller, Catherine Clinton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium StudyRegina I Jakacki, Marta Hamilton, Richard J Gilbertson, et al.
Nuclear Medicine and Biology|January 12, 2011
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibodyJason L J Dearling, Stephan D Voss, Patricia Dunning, et al.
Pediatric Blood & Cancer|January 8, 2024
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumorsKristy L Pilbeam, Kamnesh Pradhan, James Croop, et al.
Digestive Diseases and Sciences|August 22, 2022
Standard Adult Gastric Emptying Scintigraphy Criteria Is Applicable for Partial Meal IngestionHina Shah, Reethy Sundar, David E Arboleda Prado, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|June 18, 2013
A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trialDeepika Nehra, Erica M Fallon, Alexis K Potemkin, et al.
Childhood Obesity (Print)|May 28, 2013
A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese childrenMarta Ramon-Krauel, Sandra L Salsberg, Cara B Ebbeling, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2024
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)Jennifer H Foster, Joel M Reid, Charles Minard, et al.
Cancer|May 9, 2018
Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology GroupFrank G Keller, Sharon M Castellino, Lu Chen, et al.
Pediatric Blood & Cancer|October 28, 2017
Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot studyAllison F O'Neill, Stephan D Voss, Jyothi P Jagannathan, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
JCO Precision Oncology|June 22, 2022
Gamma Secretase Inhibition for a Child With Metastatic Glomus Tumor and Activated NOTCH1Ellen Zhang, Amber Miller, Catherine Clinton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium StudyRegina I Jakacki, Marta Hamilton, Richard J Gilbertson, et al.
Nuclear Medicine and Biology|January 12, 2011
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibodyJason L J Dearling, Stephan D Voss, Patricia Dunning, et al.
Pediatric Blood & Cancer|January 8, 2024
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumorsKristy L Pilbeam, Kamnesh Pradhan, James Croop, et al.
Digestive Diseases and Sciences|August 22, 2022
Standard Adult Gastric Emptying Scintigraphy Criteria Is Applicable for Partial Meal IngestionHina Shah, Reethy Sundar, David E Arboleda Prado, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|June 18, 2013
A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trialDeepika Nehra, Erica M Fallon, Alexis K Potemkin, et al.
Childhood Obesity (Print)|May 28, 2013
A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese childrenMarta Ramon-Krauel, Sandra L Salsberg, Cara B Ebbeling, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2024
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)Jennifer H Foster, Joel M Reid, Charles Minard, et al.
Cancer|May 9, 2018
Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology GroupFrank G Keller, Sharon M Castellino, Lu Chen, et al.
Pediatric Blood & Cancer|October 28, 2017
Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot studyAllison F O'Neill, Stephan D Voss, Jyothi P Jagannathan, et al.
Pageof 11